RE: America22 Jul 2020 15:10
Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was informed on 22 July 2020 that Leonard Licht, a private investor, now holds 7,770,000 ordinary shares of 1 pence each in the capital of the Company, representing 5.20% of the Company's issued share capital.